COP
Cosmo N.V.
Stock
Stock
ISIN: NL0011832936
Ticker: COPN
NL0011832936
COPN
Price
Price
CHART BY
Historical dividends and forecast
Cosmo N.V. has so far distributed $2.478 in 2026. The next dividend will be paid on 11.05.2027
$1.795
CHART BY
Frequently asked questions
What is Cosmo N.V.'s market capitalization?
The market capitalization of Cosmo N.V. is 943.76M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Cosmo N.V.?
Cosmo N.V.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.349. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Cosmo N.V.'s stock?
Currently, 5 analysts cover Cosmo N.V.'s stock, with a consensus target price of 107.89. Analyst ratings provide insights into the stock's expected performance.
What is Cosmo N.V.'s revenue over the trailing twelve months?
Over the trailing twelve months, Cosmo N.V. reported a revenue of 95.03M.
What is the EBITDA for Cosmo N.V.?
Cosmo N.V.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -559.55K. EBITDA measures the company's overall financial performance.
What is the free cash flow of Cosmo N.V.?
Cosmo N.V. has a free cash flow of -22.54M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Cosmo N.V. have, and what sector and industry does it belong to?
Cosmo N.V. employs approximately 325 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Cosmo N.V.'s shares?
The free float of Cosmo N.V. is 8.63M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 943.76M
- EPS (TTM)
- -$0.349
- Free Float
- 8.63M
- Revenue (TTM)
- 95.03M
- EBITDA (TTM)
- -559.55K
- Free Cashflow (TTM)
- -22.54M
Pricing
- 1D span
- $66.73$69.39
- 52W span
- $66.73$166.82
Analyst Ratings
The price target is 107.89 and the stock is covered by 5 analysts.
Buy
5
Hold
0
Sell
0
Information
Cosmo NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
- Employees
- 325
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- NL0011832936
- Primary Ticker
- COPN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet